The Cholesterol Myth

Why Your Brain and Body Need More Than You Think

In the modern landscape of cardiovascular health, cholesterol has become the ultimate villain. We are conditioned to view our lab results through a binary lens: lower is better, and anything breaching the 200 mg/dL threshold is a ticking time bomb. However, this clinical obsession ignores a fundamental biological reality. Cholesterol is not a poison; it is an essential nutrient. In our aggressive pursuit to suppress these levels, we may be inadvertently sabotaging our most critical organ: the brain.

Note: As an Amazon Associate, I earn from qualifying purchases. This helps support the maintenance of this blog. Please see my favorite product at the bottom of this post.

The Brain’s Vital Requirement: The human brain is an anatomical marvel, containing approximately 20% of the body’s total cholesterol (Jin et al., 2019). It is not merely a bystander in systemic metabolism; the brain requires cholesterol for structural integrity, synaptic plasticity, and effective neurotransmission (Schreurs, 2010; Jin et al., 2019).

Because the blood-brain barrier effectively isolates the central nervous system from circulating lipids, the brain synthesizes its own supply (Schreurs, 2010; Jin et al., 2019). However, the health of the body’s peripheral cholesterol levels remains vital for overall cellular function. When we force systemic cholesterol levels to plummet, particularly to below 95 mg/dL, we risk impairing fundamental biological processes, including cell membrane integrity and immune function (Bashyal, 2024). Research indicates that excessively low cholesterol is associated with increased all-cause mortality, including higher risks of stroke and certain cancers, suggesting that our "target" levels may be dangerously misguided (Nago et al., 2011).

The Statin Conundrum: A Costly Intervention

The pharmaceutical push to lower cholesterol is a multi-billion-dollar engine. Statin medications represent a cornerstone of this industry, with global sales historically reaching tens of billions annually (Thompson & Temple, 2004). While they are touted as lifesaving, their rapid adoption has coincided with an alarming rise in cognitive and neuromuscular complaints.

Statins are well-documented to cause significant side effects. Neuromuscular adverse events, ranging from muscle weakness and myalgia to more severe conditions like rhabdomyolysis, are common (Attardo et al., 2022). Beyond the muscles, many patients report persistent "brain fog," a subjective yet debilitating cognitive decline. Some researchers now express concern that aggressive cholesterol suppression may be linked to or exacerbate neurodegenerative conditions like Alzheimer’s and dementia, as we starve the body and potentially disrupt the delicate lipid balance necessary for healthy neurological function (Schreurs, 2010; Jin et al., 2019).

Author’s Personal Perspective: I may place a lot of things in my mouth, but a statin will never cross my lips.

Modern medicine has become so obsessed with these drugs that in 2004, England’s Chief Medical Officer infamously suggested adding statins to the public drinking water supply. Years later, researchers even proposed handing them out at fast-food joints like ketchup packets. This casual, mass-medication mindset ignores a devastating reality.

My mother was incredibly proud when she and her doctor successfully dropped her cholesterol from 125 to 95. Despite my pleas for her to investigate the side effects, the consequences were heartbreaking. Alzheimer’s has no history in our family, yet her cognitive health declined rapidly within a year of starting the medication. Five years later, she lost all memory of her children and family.

What many people don't realize is exactly what these drugs do to brain chemistry. The brain requires immense amounts of cholesterol to build nerve pathways and maintain memory.

Furthermore, statins work by blocking a specific cellular pathway that produces cholesterol, but the same pathway also produces Coenzyme Q10 (CoQ10). When you choke off that pathway, you don't lower cholesterol in a vacuum; you starve the brain's powerhouses of the energy they need to function.

While I refuse to take statins, I do take a daily CoQ10 capsule.

My stance is clear: supplementation is vital to protect your mind. The aging process alone naturally drains our reserves, causing us to lose roughly 10% of our natural CoQ10 levels over time. When a statin strips away what little remains, the brain is left completely defenseless. Supplementing daily helps the brain replace the lost percentage, helping maintain the cellular energy required to keep your memory sharp.

I highly recommend Qunol Ultra CoQ10 with 3X Better Absorption. Water and Fat Soluble. I have taken it for years. It keeps my mind sharp and focused.

 

If cholesterol is not the primary villain, why are we seeing a rise in heart disease? The answer lies not in eggs or dietary fats, but in the pervasive consumption of refined carbohydrates.

When we replace fats with sweets and starches, we create a metabolic environment rife with inflammation. High-sugar diets drive systemic abnormalities, including insulin resistance, elevated triglycerides, and the production of oxidized particles that damage the arterial lining (DiNicolantonio et al., 2016). These free radicals and inflammatory markers, triggered by glucose- and fructose-containing sweeteners, lead to plaque formation (DiNicolantonio et al., 2016).

A lab reading of 200–300 mg/dL may represent a healthy, robust state for many, provided those lipids are not oxidized by a diet high in processed sugars. Conversely, an "ideal" reading of 95 mg/dL achieved through synthetic suppression may leave the body vulnerable, stripping it of its most potent antioxidant and structural building block.

The Statin Conundrum: A Costly Intervention

The pharmaceutical push to lower cholesterol is a multi-billion-dollar engine. Statin medications represent a cornerstone of this industry, with global sales historically reaching tens of billions annually (Thompson & Temple, 2004). While they are touted as lifesaving, their rapid adoption has coincided with an alarming rise in cognitive and neuromuscular complaints.

As we age, we naturally, as stated, lose a significant portion, up to 10%, of the cholesterol in our brains. Stop, and think about that sentence. Statins deprive the brain of the essential component it needs to maintain memory and cognitive function. Given this biological necessity, it is worth questioning whether the introduction of multiple major statins, often released concurrently by the same pharmaceutical entities, correlates with the documented spike in dementia and Alzheimer’s diagnoses.

Statins are well-documented to cause significant side effects. Neuromuscular adverse events, ranging from muscle weakness and myalgia to more severe conditions like rhabdomyolysis, are common (Attardo et al., 2022). Beyond the muscles, many patients report persistent "brain fog," a subjective yet debilitating cognitive decline. Some researchers now express concern that aggressive cholesterol suppression may be linked to or exacerbate neurodegenerative conditions, as we starve the body and potentially disrupt the delicate lipid balance necessary for healthy neurological function (Schreurs, 2010; Jin et al., 2019).

Conclusion: The obsession with lowering cholesterol to arbitrary, low numbers is a medical approach that ignores the body’s complex needs. By focusing on the true culprits, refined sugars and inflammatory starches, we can protect our arteries without sacrificing the essential building blocks required for cognitive clarity and physical vitality. It is time to move past the cholesterol myth and embrace a more nuanced understanding of what truly keeps our hearts and brains healthy.

Your Author highly recommends: The Great Cholesterol Myth, Revised and Expanded. Jonny Bowden and Stephen T. Sinatra synthesize information from various sources to support their arguments on the devastating effects of statin medications. I encourage you to read the reviews on this book left by those prescribed statins who had a wake-up call.

 
The literature and context surrounding Jonny Bowden and Stephen T. Sinatra often point to the following types of references:

Critiques of Established Studies: The authors frequently challenge the "Seven Countries Study" by Ancel Keys, often cited as the foundational research for dietary recommendations to limit saturated fat and cholesterol. They argue that this study was "cherry-picked" and that a broader look at global data reveals different correlations between fat consumption and heart disease.

Alternative Cardiovascular Metrics: The book emphasizes studies that focus on markers it believes are more predictive of heart disease than total cholesterol. These include:

Inflammation markers, Triglyceride levels, and triglyceride-to-HDL ratios

Homocysteine and fibrinogen levels, Insulin resistance, and high glycemic levels

Statin Efficacy Debates: The authors argue that statin data are often reported in ways that favor pharmaceutical interests. They point to analyses suggesting that for certain populations (such as women or those without existing heart disease), the mortality benefits of statins are less clear than traditionally presented.

Scientific Disagreement: It is important to clarify that the scientific community largely disagrees with the interpretations presented in this book. The studies referenced by Bowden and Sinatra are frequently viewed by mainstream medical organizations, such as the American Heart Association, as outliers or as misinterpretations of the broader body of clinical evidence supporting the use of statins and the management of LDL cholesterol.

Research on both high-protein and high-carbohydrate diets reveals distinct pathways by which each can negatively affect cardiovascular health and arterial wall integrity.

Impact of High-Protein Diets: Recent studies suggest that excessive protein intake may contribute to plaque development and instability.

Mechanism of Action: When protein intake exceeds roughly 22% of daily calories, amino acids, particularly leucine, over-activate a protein in immune cells called mTOR.

Arterial Impact: This overactivation disrupts the cleaning duties of macrophages (immune cells that clear debris from arterial walls). Instead of performing "housecleaning," these cells grow, die, and accumulate within the vessel walls, creating a "graveyard" of dead cells that increases plaque complexity and instability.

Risk Factors: Unstable plaques are more prone to rupture, which can lead to blocked arteries and heart attacks.

Impact of High-Carbohydrate and Sugar-Rich Diets: Diets high in refined carbohydrates and added sugars are frequently associated with systemic inflammation and oxidative stress, which directly affect arterial health.

Free Radical Formation: Consumption of refined carbohydrates has been linked to increased production of free radicals (such as superoxide) and endothelial oxidative stress, which reduces the ability of blood vessels to function correctly.

Inflammation and Plaque: Excessive sugar intake can drive chronic systemic inflammation and elevate inflammatory markers (such as CRP, IL-6, and TNF-α), which are key predictors of cardiovascular disease.

Metabolic Changes: Sugary diets can overwhelm the liver, leading to increased production of triglycerides and harmful LDL cholesterol particles, both of which contribute to the accumulation of artery-clogging plaque.

Quality Matters: Research indicates that the quality of carbohydrates is paramount; diets rich in fiber from whole fruits and vegetables provide polyphenols and minerals that help maintain healthy blood vessels, whereas refined sugars provide "empty" calories that promote weight gain and insulin resistance.

Summary Comparison

Dietary Focus, Primary Cardiovascular Concern, Key Mechanism

High Protein (>22% kcal), Increased plaque instability and "macrophage graveyards" Activation of mTOR via amino acids like leucine |

High Refined Carbs/Sugar, Systemic inflammation and endothelial dysfunction, Increased oxidative stress and free radical production

While both diet types can negatively affect arteries, they do so through different biological pathways. Experts often suggest that the key lies in viewing the diet as balanced meals rather than relying on extreme macronutrient ratios.

Blog Disclaimer: I am using my First Amendment rights in the content I share on this blog. The views and opinions expressed in this blog are solely those of the author and do not necessarily represent the views of any organization or institution with which the author may be affiliated. The content provided on this blog is for informational purposes only and should not be considered professional advice. Always consult with a qualified professional for any specific concerns or questions you may have.

About the Author: Kat Kaelin is a retired Kentucky Probation and Parole officer and an alumna of Western Kentucky University with a B.S. in Behavioral Science and an MFA in Creative Writing and Publishing, and a background in Research and Statistical Analysis. Her professional background includes the U.S. Army Medical Corps and a separate 10-year enlistment in the U.S. Army 100th Division. A ghostwriter for over 40 years, she writes under the professional name Cecilia Payne-Kat Kaelin.

Join me for more true stories taken from life, service, silence, and the human spirit. Thank you for being part of this journey. By sharing our message, we form an alliance of faith, hope, truth, love, and trust, and we flourish and unite nationally and globally.

References: Attardo, S., Musumeci, O., Velardo, D., & Toscano, A. 2022. Statins' neuromuscular adverse effects. International Journal of Molecular Sciences, 23(15), 8364. https://doi.org/10.3390/ijms23158364 Cited by: 150

Bashyal, S. 2024. Conundrum of cholesterol management and health implications of low cholesterol levels: A narrative review. PMC. Cited by: 0

DiNicolantonio, J. J., Lucan, S. C., & O’Keefe, J. H. 2016. The evidence for saturated fat and sugar related to coronary heart disease. Progress in Cardiovascular Diseases, 58 (4), 464–472. https://doi.org/10.1016/j.pcad.2015.11.006 Cited by: 452

Jin, U., Park, S. J., & Park, S. M. 2019. Cholesterol metabolism in the brain and its association with Parkinson’s disease. Experimental Neurobiology, 28 (5), 554–567. https://doi.org/10.5607/en.2019.28.5.554 Cited by: 189

Nago, N., Ishikawa, S., Goto, T., & Kayaba, K. 2011. Low cholesterol is associated with mortality from stroke, heart disease, and cancer: The Jichi Medical School Cohort Study. Journal of Epidemiology, 21 (1), 67–74. https://doi.org/10.2188/jea.je20100065 Cited by: 140

Schreurs, B. G. 2010. The effects of cholesterol on learning and memory. Neuroscience & Biobehavioral Reviews, 34 (8), 1366–1379. https://doi.org/10.1016/j.neubiorev.2010.04.010 Cited by: 147

Thompson, A., & Temple, N. J. 2004. The case for statins: Has it really been made? Journal of the Royal Society of Medicine, 97 (10), 461–464. https://doi.org/10.1177/0141076809701002 Cited by: 30

We are strongest when we link together in a global chain that circles the world. You are never powerless. Use your mind, your voice, and your unique talents to make an impact—and start by sharing this content with the people you care about.